Sprucegrove Investment Management Ltd. cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 11.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 87,864 shares of the biopharmaceutical company’s stock after selling 11,736 shares during the […]